About
Our mission
Governance
Partners
Science
Our Genome Engineering Platform
TALEN® Technology
In-House Manufacturing
Pipeline
Product Candidates
Investors
IR Overview
News
Press releases
Events and Webcasts
Presentations
Corporate presentations
Scientific presentations
Scientific publications
Corporate Governance
Board of Directors
Executive Committee
External Auditors
Governance Documents
General meetings
Financial Information
SEC filings
Financial statements
Voting Rights & Share Capital
Stock information
Shareholders Services
IR Inquiries
IR FAQ
Careers
Our culture
Job opportunities
Contact us
FR
Recherche
›
Press releases
About
Our mission
Governance
Partners
Science
Our Genome Engineering Platform
TALEN® Technology
In-House Manufacturing
Pipeline
Product Candidates
Investors
IR Overview
News
Press releases
Events and Webcasts
Presentations
Corporate presentations
Scientific presentations
Scientific publications
Corporate Governance
Board of Directors
Executive Committee
External Auditors
Governance Documents
General meetings
Financial Information
SEC filings
Financial statements
Voting Rights & Share Capital
Stock information
Shareholders Services
IR Inquiries
IR FAQ
Careers
Our culture
Job opportunities
Contact us
FR
Press releases
All
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
16
Apr 2015
20:30 E.S.T.
Cellectis Plant Sciences, Inc. Locks Early CRISPR Intellectual Property Uses in Plants
Read more
15
Apr 2015
20:30 E.S.T.
Cellectis Plant Sciences, Inc. Publishes a Study Demonstrating Reduced Acrylamide in Fried Potatoes
Read more
9
Apr 2015
20:30 E.S.T.
Cellectis Opens Labs and Offices in Manhattan, New York
Read more
25
Mar 2015
20:30 E.S.T.
Cellectis Prices Initial Public Offering of American Depositary Shares
Read more
4
Mar 2015
21:30 E.S.T.
Cellectis: 2014 financial results
Read more
17
Feb 2015
21:30 E.S.T.
Cellectis SA Shareholders General Meeting of February 16, 2015
Read more
13
Jan 2015
21:30 E.S.T.
Cellectis and The Ohio State University, Through the Ohio State Innovation Foundation, Enter Into Licensing Agreement for Chimeric Antigen Receptor Technology Targeting Multiple Myeloma
Read more
8
Jan 2015
21:30 E.S.T.
Cellectis Plans to Conduct Registered Initial Public Offering in the U.S.
Read more
6
Jan 2015
21:30 E.S.T.
Cellectis announces the issuance by the USPTO of a patent covering a seminal nuclease-based “gene editing” method
Read more
Posts pagination
← PREV
1
2
3
Press contacts
For more information on any story, or for press enquiries, get in touch with our communication team
CONTACT US